Cti Biopharma reported $123.47M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Applied Genetic Technologies AGTC:US USD 57.33M 9.35M
Baxter International BAX:US USD 27.97B 3.87B
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Cti Biopharma CTIC:US USD 123.47M 11.07M
Cytori Therapeutics CYTX:US USD 23.1M 1.83M
Eli Lilly And LLY:US USD 47.46B 397.9M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Northwest Biotherapeutics NWBO:US USD 31.1M 3.58M
Novartis NOVN:VX USD 118.46B 4.45B
Novartis NVS:US USD 118.46B 4.45B
Seattle Genetics SGEN:US USD 3.62B 11.26M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
YTE INCY:US USD 5.51B 191.18M